Interventions for Menière's disease: an umbrella systematic review

Babette Fiebke van Esch1,2, Hester van der Zaag-Loonen3, Tjasse Bruintjes3

  • 1Apeldoorn Dizziness Centre, Gelre Ziekenhuizen, Apeldoorn, The Netherlands B.F.van_Esch@lumc.nl.

Abstract

Insights

Current Meniere's disease treatments like betahistine and pressure therapy show limited efficacy. While some injections and surgery may help, definitive effective therapies for Meniere's disease are still needed.

Area of Science:

  • Otolaryngology
  • Neurology
  • Clinical Trials

Background:

  • Meniere's disease (MD) is a chronic inner ear disorder characterized by vertigo, tinnitus, and hearing loss.
  • Effective and well-tolerated treatments for MD remain a significant clinical challenge.

Purpose of the Study:

  • To systematically review the efficacy of various interventions for Meniere's disease.
  • To provide clinical implications and identify research gaps for MD treatments.

Main Methods:

  • A systematic review of randomized controlled trials (RCTs) was conducted using PRISMA-A guidelines.
  • Searches included MEDLINE, Embase, and CENTRAL databases up to May 2021, supplemented by a separate RCT search.
  • The primary outcome was vertigo control; evidence certainty was assessed using the GRADE approach.

Main Results:

  • Twenty-five RCTs (n=1248) evaluated betahistine, intratympanic gentamicin/steroids, endolymphatic sac surgery, and pressure pulse therapy.
  • Evidence for most MD interventions is of low certainty.
  • Betahistine and pressure pulse therapy likely show no significant benefit over placebo; intratympanic injections and surgery may offer symptom reduction.

Conclusions:

  • No definitive, well-tolerated therapy for Meniere's disease has been established.
  • A lack of data on the natural disease course is a major limitation in current MD research.

Related Concept Videos

Mitral Regurgitation III: Medical Management01:25

Mitral Regurgitation III: Medical Management

Mitral regurgitation (MR) is characterized by retrograde blood circulation from the left ventricle into the left atrium due to inadequate mitral valve closure. The severity of the condition, symptoms, and underlying cause determine treatment strategies.Monitoring and Pharmacological TreatmentPatients with mild to moderate MR typically do not need immediate intervention but regular monitoring to assess progression and guide treatment. Patients with mild MR should have an echocardiogram every 3-5...
51
Mitral Stenosis III: Medical Management01:26

Mitral Stenosis III: Medical Management

Mitral stenosis, a condition marked by the narrowing of the mitral valve, necessitates an integrated approach for effective management. This approach includes preventative measures, medical therapy, and surgical interventions to reduce symptoms and prevent complications.PreventionPrevention of mitral stenosis primarily focuses on reducing the incidence of bacterial infections, particularly streptococcal infections, which can lead to rheumatic fever and subsequent valvular damage. Timely...
42
Open Angle Glaucoma: Treatment01:27

Open Angle Glaucoma: Treatment

In open-angle glaucoma, the iridocorneal angle remains open, but the trabecular meshwork becomes stiff, slowing down the outflow of aqueous humor. This causes a buildup of aqueous humor in the anterior chamber, leading to a sudden increase in intraocular pressure. The treatment for open-angle glaucoma focuses on reducing the elevated intraocular pressure by either decreasing the secretion of aqueous humor or increasing its outflow.
Drugs such as carbonic anhydrase inhibitors, α2- and...
748
Mitral Regurgitation IV: Nursing Management01:28

Mitral Regurgitation IV: Nursing Management

Mitral regurgitation (MR) is a condition where the mitral valve does not close properly, leading to the backward flow of blood from the left ventricle into the left atrium during systole. This condition can arise from various causes, including rheumatic fever, infective endocarditis, or degenerative valve disease. Effective nursing management is crucial to optimizing patient outcomes and involves comprehensive assessment and targeted interventions.Comprehensive Patient AssessmentA detailed...
120
Mitral Valve Prolapse II: Assessment and Management01:22

Mitral Valve Prolapse II: Assessment and Management

IntroductionA range of clinical features characterizes Mitral Valve Prolapse (MVP), but it is important to note that many individuals with MVP are asymptomatic and may remain so throughout their lives. For those who do exhibit symptoms, the following are the key clinical features:Palpitations: This is a common symptom where individuals feel an irregular or rapid heartbeat. Palpitations in MVP are often due to arrhythmias such as premature ventricular contractions or supraventricular...
67
Nephrotic Syndrome II : Assessment and Medical Management01:26

Nephrotic Syndrome II : Assessment and Medical Management

IntroductionNephrotic syndrome is a kidney disorder marked by excessive protein loss in the urine, leading to various systemic complications. This condition often results from damage to the glomeruli—the kidney's filtering units—causing proteinuria, low blood protein levels, and fluid retention. Understanding the assessment, diagnosis, and management of nephrotic syndrome is essential for effective treatment and prevention of further kidney damage.AssessmentPatient History: Document...
35